(Q50319665)

3 March 2018

case report

0 references

title

Effects of the Concomitant Use of Low-dose Clarithromycin with an Anti-TNFα Antibody in a Patient with Intestinal Behçet Disease. (English)

1 reference

3 March 2018

0 references

1 reference

Akira Honda

9

0 references

author name string

Junichi Iwamoto

1

1 reference

3 March 2018

Masashi Murakami

2

1 reference

3 March 2018

Naoki Konishi

3

1 reference

3 March 2018

Tadakuni Monma

4

1 reference

3 March 2018

Hajime Ueda

5

1 reference

3 March 2018

Shoichiro Yara

6

1 reference

3 March 2018

Takeshi Hirayama

7

1 reference

3 March 2018

Tadashi Ikegami

8

1 reference

3 March 2018

Yasushi Matsuzaki

10

1 reference

3 March 2018

publication date

1 November 2017

1 reference

3 March 2018

published in

Internal Medicine

1 reference

3 March 2018

volume

57

1 reference

3 March 2018

issue

3

1 reference

3 March 2018

page(s)

339-342

1 reference

3 March 2018

Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5827312

Diagnosis and management of intestinal Behçet's disease.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5827312

Efficacy of infliximab in patients with intestinal Behçet's disease refractory to conventional medication

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5827312

Effective Treatment of Intestinal Behçet's Disease with Long-Term, Low-Dose Clarithromycin

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5827312

Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5827312

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5827312

Immunotherapy for Behçet's disease

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5827312

Modulatory effect of antibiotics on cytokine production by human monocytes in vitro

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5827312

Therapeutic effect of intraarterial prednisolone injection in severe intestinal Behçet's disease

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5827312

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5827312

Open label trial of clarithromycin therapy in Japanese patients with Crohn's disease

2 November 2018

1 reference

12 December 2020

Long-term clinical outcomes and factors predictive of relapse after 5-aminosalicylate or sulfasalazine therapy in patients with intestinal Behcet disease

1 reference

12 December 2020

Adalimumab for the treatment of Japanese patients with intestinal Behçet's disease

1 reference

12 December 2020

Postoperative recurrence in patients with intestinal Behçet's disease

1 reference

12 December 2020

1 reference

12 December 2020

Immunological and anti-inflammatory effects of clarithromycin: inhibition of interleukin 1 production of murine peritoneal macrophages

1 reference

12 December 2020

10.2169/INTERNALMEDICINE.9322-17

Identifiers

DOI

1 reference

3 March 2018

release_24l6hpmjavhj7l7sbthp4prprq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/24l6hpmjavhj7l7sbthp4prprq

24 November 2022

mapped directly with Wikidata item

PMCID

5827312

1 reference

3 March 2018

PubMed ID

29093413

1 reference

3 March 2018